Product Images Norgestimate And Ethinyl Estradiol
View Photos of Packaging, Labels & Appearance
Product Label Images
The following 6 images provide visual information about the product associated with Norgestimate And Ethinyl Estradiol NDC 72789-434 by Pd-rx Pharmaceuticals, Inc., such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.
72789434 Label - 72789434
This is a medication packaging for Norgestimate/Ethinyl Estradiol tablets with a dosage of 0.250mg/0.035mg per tablet. Each pack contains 28 tablets. The prescription details include the ReOrder# 111613, Lot 10005476, and expiration date 04/2025. The packaging mentions to consult a doctor for medical advice on side effects and to report any side effects to the FDA. The tablets are color-coded with blue tablets containing the active ingredients and white tablets containing inert ingredients. The tablets are round in shape and have an organoleptic marking of "b3". The NDC number, pharmaceutical company information, and contact information are also provided on the packaging.*
norgestimate structural formula - image 01
"NOT AVAILABLE"*
ethinyl estradiol structural formula - image 02
Fewer-More Pregnancies Image - image 03
This text lists various birth control methods such as implants, injections, intrauterine devices, sterilization, birth control pills, skin patch, vaginal ring with hormones, condoms, diaphragm, avoiding sex during the most fertile days of the monthly cycle, spermicide, and withdrawal. This information is helpful for individuals looking for different contraceptive options.*
blister image - image 04
blister image - image 05
* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.
